Almost half of patients diagnosed with depression classify as being ‘treatment-resistant’ as new research suggests that many don’t respond to multiple antidepressant options. The new study, published ...
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...
A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
– Issued and pending claims expected to protect ALTO-207 into the mid-2040s – MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical ...
Interesting Engineering on MSN
FDA clears first US trial of wireless brain implant for treatment-resistant depression
A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...
AUSTIN (KXAN)- Experts estimate that treatment-resistant depression (TRD) impacts about 2.8 million Americans annually, and a groundbreaking implantable device may offer new hope. Depression affects ...
Forbes contributors publish independent expert analyses and insights. I am a therapist, executive coach and author. The gentle tapping sound reminds me of a woodpecker–rhythmic and purposeful. I'm ...
Repetitive transcranial magnetic stimulation is already FDA approved for major depressive disorder. Researchers think it could offer drug-free relief for moms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results